{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:10:14Z","timestamp":1769217014198,"version":"3.49.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900738"],"award-info":[{"award-number":["81900738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11302-022-09858-2","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:03:00Z","timestamp":1648504980000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Purinergic signaling in thyroid disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Ying","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-138X","authenticated-orcid":false,"given":"Meng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"9858_CR1","doi-asserted-by":"publisher","DOI":"10.4324\/9780203450437","volume-title":"Endocrinology: an integrated approach","author":"S Nussey","year":"2001","unstructured":"Nussey S, Whitehead S (2001) Endocrinology: an integrated approach. BIOS Scientific Publishers, Oxford"},{"key":"9858_CR2","unstructured":"Mariotti S, Beck-Peccoz P (2000) Physiology of the hypothalamic-pituitary-thyroid axis: 1\u201363"},{"key":"9858_CR3","unstructured":"Pirahanchi Y, Tariq MA, Jialal I (2021) Physiology, Thyroid: 1\u20139"},{"key":"9858_CR4","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1530\/EC-18-0029","volume":"7","author":"BB Mughal","year":"2018","unstructured":"Mughal BB, Fini JB, Demeneix BA (2018) Thyroid-disrupting chemicals and brain development: an update. Endocr Connect 7:R160\u2013R186","journal-title":"Endocr Connect"},{"key":"9858_CR5","unstructured":"Shahid MA, Ashraf MA, Sharma S (2021) Physiology, Thyroid Hormone: 1\u201314"},{"key":"9858_CR6","doi-asserted-by":"publisher","first-page":"T145","DOI":"10.1530\/JOE-18-0704","volume":"242","author":"NN Chattergoon","year":"2019","unstructured":"Chattergoon NN (2019) Thyroid hormone signaling and consequences for cardiac development. J Endocrinol 242:T145\u2013T160","journal-title":"J Endocrinol"},{"key":"9858_CR7","unstructured":"Armstrong M, Asuka E, Fingeret A (2021) Physiology, Thyroid Function: 1\u20136"},{"key":"9858_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343\u20131421","journal-title":"Thyroid"},{"key":"9858_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2967\/jnumed.120.243170","volume":"62","author":"G Mariani","year":"2021","unstructured":"Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW (2021) The role of nuclear medicine in the clinical management of benign thyroid disorders, part 1: hyperthyroidism. J Nucl Med 62:304\u2013312","journal-title":"J Nucl Med"},{"key":"9858_CR10","doi-asserted-by":"crossref","unstructured":"Mathew P, Rawla P (2021) Hyperthyroidism: 1\u201314","DOI":"10.56330\/XDWP5331"},{"key":"9858_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0576","volume":"176","author":"OM Dekkers","year":"2017","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, Cannegieter SC, Vandenbroucke JP, S\u00f8rensen HT, J\u00f8rgensen JO (2017) Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study. Eur J Endocrinol 176:1\u20139","journal-title":"Eur J Endocrinol"},{"key":"9858_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/thy.2018.0320","volume":"29","author":"M Lillevang-Johansen","year":"2019","unstructured":"Lillevang-Johansen M, Abrahamsen B, J\u00f8rgensen HL, Brix TH, Heged\u00fcs L (2019) Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk. Thyroid 29:332\u2013340","journal-title":"Thyroid"},{"key":"9858_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1089\/thy.2019.0543","volume":"30","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Kang T, Kang MJ, Ahn HS, Sohn SY (2020) Incidence and mortality of myocardial infarction and stroke in patients with hyperthyroidism: a nationwide cohort study in Korea. Thyroid 30:955\u2013965","journal-title":"Thyroid"},{"key":"9858_CR14","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1210\/jc.2006-2644","volume":"92","author":"M Homoncik","year":"2007","unstructured":"Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H (2007) Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 92:3006\u20133012","journal-title":"J Clin Endocrinol Metab"},{"key":"9858_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1530\/EJE-14-0801","volume":"172","author":"J Horacek","year":"2015","unstructured":"Horacek J, Maly J, Svilias I, Smolej L, Cepkova J, Vizda J, Sadilek P, Fatorova I, Zak P (2015) Prothrombotic changes due to an increase in thyroid hormone levels. Eur J Endocrinol 172:537\u2013542","journal-title":"Eur J Endocrinol"},{"key":"9858_CR16","unstructured":"Shahat AS, Hassan WA, El-Sayed WM (2020) N-Acetylcysteine and Safranal prevented the brain damage induced by hyperthyroidism in adult male rats. Nutr Neurosci 3:1\u201315"},{"key":"9858_CR17","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.18632\/oncotarget.14060","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Zhi M, Hou Z, Zhang Y, Yue Y, Yuan Y (2017) Abnormal brain functional connectivity leads to impaired mood and cognition in hyperthyroidism: a resting-state functional MRI study. Oncotarget 8:6283\u20136294","journal-title":"Oncotarget"},{"key":"9858_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbr.2018.05.020","volume":"351","author":"M Zhi","year":"2018","unstructured":"Zhi M, Hou Z, We Q, Zhang Y, Li L, Yuan Y (2018) Abnormal spontaneous brain activity is associated with impaired emotion and cognition in hyperthyroidism: a rs-fMRI study. Behav Brain Res 351:188\u2013194","journal-title":"Behav Brain Res"},{"key":"9858_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism Lancet 390:1550\u20131562","journal-title":"Hypothyroidism Lancet"},{"key":"9858_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/thy.2017.0414","volume":"28","author":"S Moon","year":"2018","unstructured":"Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ (2018) Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid 28:1101\u20131110","journal-title":"Thyroid"},{"key":"9858_CR21","unstructured":"Patil N, Rehman A, Jialal I (2021) Hypothyroidism: 1\u201313"},{"key":"9858_CR22","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s12035-018-1270-y","volume":"56","author":"P Salazar","year":"2019","unstructured":"Salazar P, Cisternas P, Martinez M, Inestrosa NC (2019) Hypothyroidism and cognitive disorders during development and adulthood: implications in the central nervous system. Mol Neurobiol 56:2952\u20132963","journal-title":"Mol Neurobiol"},{"key":"9858_CR23","doi-asserted-by":"publisher","first-page":"586939","DOI":"10.3389\/fnins.2020.586939","volume":"14","author":"K G\u0142ombik","year":"2020","unstructured":"G\u0142ombik K, Detka J, Kurek A, Budziszewska B (2020) Impaired brain energy metabolism: involvement in depression and hypothyroidism. Front Neurosci 14:586939","journal-title":"Front Neurosci"},{"key":"9858_CR24","doi-asserted-by":"publisher","first-page":"102473","DOI":"10.1016\/j.nicl.2020.102473","volume":"28","author":"B Liu","year":"2020","unstructured":"Liu B, Wang Z, Lin L, Yang H, Gao F, Gong T, Edden R, Wang G (2020) Brain GABA+ changes in primary hypothyroidism patients before and after levothyroxine treatment: a longitudinal magnetic resonance spectroscopy study. Neuroimage Clin 28:102473","journal-title":"Neuroimage Clin"},{"key":"9858_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11307-018-1182-2","volume":"20","author":"H Wang","year":"2018","unstructured":"Wang H, Tan Z, Zheng Q, Yu J (2018) Metabolic brain network analysis of hypothyroidism symptom based on [(18)F]FDG-PET of rats. Mol Imaging Biol 20:789\u2013797","journal-title":"Mol Imaging Biol"},{"key":"9858_CR26","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1089\/thy.2017.0362","volume":"28","author":"K Ro","year":"2018","unstructured":"Ro K, Yuen AD, Du L, Ro CC, Seger C, Yeh MW, Leung AM, Rhee CM (2018) Impact of hypothyroidism and heart failure on hospitalization risk. Thyroid 28:1094\u20131100","journal-title":"Thyroid"},{"key":"9858_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-19-0006","volume":"180","author":"M Lillevang-Johansen","year":"2019","unstructured":"Lillevang-Johansen M, Abrahamsen B, J\u00f8rgensen HL, Brix TH, Heged\u00fcs L (2019) Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol 180:407\u2013416","journal-title":"Eur J Endocrinol"},{"key":"9858_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","volume":"15","author":"Y Ning","year":"2017","unstructured":"Ning Y, Cheng YJ, Liu LJ, Sara JD, Cao ZY, Zheng WP, Zhang TS, Han HJ, Yang ZY, Zhang Y, Wang FL, Pan RY, Huang JL, Wu LL, Zhang M, Wei YX (2017) What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. Bmc Med 15:21","journal-title":"Bmc Med"},{"key":"9858_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.numecd.2017.07.002","volume":"27","author":"G Desideri","year":"2017","unstructured":"Desideri G, Bocale R, D\u2019Amore A, Necozione S, Boscherini M, Carnassale G, Barini A, Barini A, Bellantone R, Lombardi CP (2017) Replacement therapy with levothyroxine modulates platelet activation in recent-onset post-thyroidectomy subclinical hypothyroidism. Nutr Metab Cardiovasc Dis 27:896\u2013901","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"9858_CR30","first-page":"e13306","volume":"51","author":"XK Fran\u00e7ois","year":"2019","unstructured":"Fran\u00e7ois XK, Patrick BD, Modeste WN, Esther N, Albert K, Pierre K, Pierre W (2019) Preventive effects of Aframomum melegueta extracts on the reproductive complications of propylthiouracil-induced hypothyroidism in male rat. Andrologia 51:e13306","journal-title":"Andrologia"},{"key":"9858_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974\u20132013. JAMA 317:1338\u20131348","journal-title":"JAMA"},{"key":"9858_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1210\/er.2019-00085","volume":"40","author":"D Mcleod","year":"2019","unstructured":"Mcleod D, Zhang L, Durante C, Cooper DS (2019) Contemporary debates in adult papillary thyroid cancer management. Endocr Rev 40:1481\u20131499","journal-title":"Endocr Rev"},{"key":"9858_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH (2019) Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci 16:450\u2013460","journal-title":"Int J Med Sci"},{"key":"9858_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","volume":"17","author":"M Schlumberger","year":"2021","unstructured":"Schlumberger M, Leboulleux S (2021) Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol 17:176\u2013188","journal-title":"Nat Rev Endocrinol"},{"key":"9858_CR35","unstructured":"Lee K, Anastasopoulou C, Chandran C, Cassaro S (2021) Thyroid Cancer: 1\u201310"},{"key":"9858_CR36","first-page":"509","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509\u2013581","journal-title":"Pharmacol Rev"},{"key":"9858_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162","journal-title":"Signal Transduct Target Ther"},{"key":"9858_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.autneu.2015.04.010","volume":"191","author":"I Bjelobaba","year":"2015","unstructured":"Bjelobaba I, Janjic MM, Stojilkovic SS (2015) Purinergic signaling pathways in endocrine system. Auton Neurosci 191:102\u2013116","journal-title":"Auton Neurosci"},{"key":"9858_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11302-018-9629-0","volume":"14","author":"M Cie\u015blak","year":"2018","unstructured":"Cie\u015blak M, Wojtczak A (2018) Role of purinergic receptors in the Alzheimer\u2019s disease. Purinergic Signal 14:331\u2013344","journal-title":"Purinergic Signal"},{"key":"9858_CR40","doi-asserted-by":"publisher","first-page":"111273","DOI":"10.1016\/j.biopha.2021.111273","volume":"137","author":"KP Reichert","year":"2021","unstructured":"Reichert KP, Castro M, Assmann CE, Bottari NB, Miron VV, Cardoso A, Stefanello N, Morsch V, Schetinger M (2021) Diabetes and hypertension: pivotal involvement of purinergic signaling. Biomed Pharmacother 137:111273","journal-title":"Biomed Pharmacother"},{"key":"9858_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661","journal-title":"Front Pharmacol"},{"key":"9858_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcp.2017.07.016","volume":"151","author":"G Burnstock","year":"2018","unstructured":"Burnstock G (2018) The therapeutic potential of purinergic signalling. Biochem Pharmacol 151:157\u2013165","journal-title":"Biochem Pharmacol"},{"key":"9858_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11302-019-09680-3","volume":"15","author":"E Vel\u00e1zquez-Miranda","year":"2019","unstructured":"Vel\u00e1zquez-Miranda E, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2019) Purinergic signaling in hepatic disease. Purinergic Signal 15:477\u2013489","journal-title":"Purinergic Signal"},{"key":"9858_CR44","doi-asserted-by":"crossref","unstructured":"Bartoli F, Burnstock G, Crocamo C, Carr\u00e0 G (2020) Purinergic signaling and related biomarkers in depression. Brain Sci 10:160","DOI":"10.3390\/brainsci10030160"},{"key":"9858_CR45","doi-asserted-by":"publisher","first-page":"114393","DOI":"10.1016\/j.bcp.2020.114393","volume":"187","author":"S Jain","year":"2021","unstructured":"Jain S, Jacobson KA (2021) Purinergic signaling in diabetes and metabolism. Biochem Pharmacol 187:114393","journal-title":"Biochem Pharmacol"},{"key":"9858_CR46","doi-asserted-by":"publisher","first-page":"434727","DOI":"10.1155\/2013\/434727","volume":"2013","author":"GF Silveira","year":"2013","unstructured":"Silveira GF, Buffon A, Bruno AN (2013) New approaches to thyroid hormones and purinergic signaling. J Thyroid Res 2013:434727","journal-title":"J Thyroid Res"},{"key":"9858_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11302-013-9396-x","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G (2014) Purinergic signalling in endocrine organs. Purinergic Signal 10:189\u2013231","journal-title":"Purinergic Signal"},{"key":"9858_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.bjp.0703325","volume":"130","author":"M Vainio","year":"2000","unstructured":"Vainio M, Fredholm BB, T\u00f6rnquist K (2000) Thyrotropin regulates adenosine A(1) receptor expression in rat thyroid FRTL-5 cells. Br J Pharmacol 130:471\u2013477","journal-title":"Br J Pharmacol"},{"key":"9858_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1469-7580.2001.19850569.x","volume":"198","author":"R Glass","year":"2001","unstructured":"Glass R, Burnstock G (2001) Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid. J Anat 198:569\u2013579","journal-title":"J Anat"},{"key":"9858_CR50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jcp.1070","volume":"187","author":"E Ekokoski","year":"2001","unstructured":"Ekokoski E, Webb TE, Simon J, T\u00f6rnquist K (2001) Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells. J Cell Physiol 187:166\u2013175","journal-title":"J Cell Physiol"},{"key":"9858_CR51","doi-asserted-by":"publisher","first-page":"C992","DOI":"10.1152\/ajpcell.00538.2003","volume":"287","author":"MY Kochukov","year":"2004","unstructured":"Kochukov MY, Ritchie AK (2004) A P2X7 receptor stimulates plasma membrane trafficking in the FRTL rat thyrocyte cell line. Am J Physiol Cell Physiol 287:C992\u2013C1002","journal-title":"Am J Physiol Cell Physiol"},{"key":"9858_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00232-005-0742-y","volume":"204","author":"MY Kochukov","year":"2005","unstructured":"Kochukov MY, Ritchie AK (2005) P2X7 receptor stimulation of membrane internalization in a thyrocyte cell line. J Membr Biol 204:11\u201321","journal-title":"J Membr Biol"},{"key":"9858_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0898-6568(01)00208-X","volume":"14","author":"S Marsigliante","year":"2002","unstructured":"Marsigliante S, Elia MG, Di Jeso B, Greco S, Muscella A, Storelli C (2002) Increase of [Ca(2+)](i) via activation of ATP receptors in PC-Cl3 rat thyroid cell line. Cell Signal 14:61\u201367","journal-title":"Cell Signal"},{"key":"9858_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0143-4160(02)00196-3","volume":"33","author":"MG Elia","year":"2003","unstructured":"Elia MG, Muscella A, Greco S, Vilella S, Storelli C, Marsigliante S (2003) Disturbances in purinergic [Ca2+]i signaling pathways in a transformed rat thyroid cell line. Cell Calcium 33:59\u201368","journal-title":"Cell Calcium"},{"key":"9858_CR55","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/en.2004-1527","volume":"146","author":"N Caraccio","year":"2005","unstructured":"Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani C, Di Virgilio F, Ferrannini E, Solini A (2005) Extracellular adenosine 5\u2019-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology 146:3172\u20133178","journal-title":"Endocrinology"},{"key":"9858_CR56","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1210\/en.2012-2258","volume":"154","author":"L Zhang","year":"2013","unstructured":"Zhang L, Xu J, Sun N, Cai H, Ren M, Zhang J, Yu C, Wang Z, Gao L, Zhao J (2013) The presence of adenosine A2a receptor in thyrocytes and its involvement in Graves\u2019 IgG-induced VEGF expression. Endocrinology 154:4927\u20134938","journal-title":"Endocrinology"},{"key":"9858_CR57","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1042\/bj20031015","volume":"375","author":"AP Arruda","year":"2003","unstructured":"Arruda AP, Da-Silva WS, Carvalho DP, De Meis L (2003) Hyperthyroidism increases the uncoupled ATPase activity and heat production by the sarcoplasmic reticulum Ca2+-ATPase. Biochem J 375:753\u2013760","journal-title":"Biochem J"},{"key":"9858_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/biof.133","volume":"37","author":"AN Bruno","year":"2011","unstructured":"Bruno AN, Carneiro-Ramos MS, Buffon A, Pochmann D, Ricachenevsky FK, Barreto-Chaves ML, Sarkis JJ (2011) Thyroid hormones alter the adenine nucleotide hydrolysis in adult rat blood serum. BioFactors 37:40\u201345","journal-title":"BioFactors"},{"key":"9858_CR59","first-page":"254","volume":"46","author":"W Hong","year":"2016","unstructured":"Hong W, Li G, Nie Y, Zou L, Zhang X, Liu S, Li G, Xu H, Zhang CP, Liang S (2016) Potential involvement of P2 receptors in the pathological processes of hyperthyroidism: a pilot study. Ann Clin Lab Sci 46:254\u2013259","journal-title":"Ann Clin Lab Sci"},{"key":"9858_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0736-5748(03)00088-1","volume":"21","author":"AN Bruno","year":"2003","unstructured":"Bruno AN, Da SR, Bonan CD, Battastini AM, Barreto-Chaves ML, Sarkis JJ (2003) Hyperthyroidism modifies ecto-nucleotidase activities in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int J Dev Neurosci 21:401\u2013408","journal-title":"Int J Dev Neurosci"},{"key":"9858_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpb.2004.11.007","volume":"140","author":"AN Bruno","year":"2005","unstructured":"Bruno AN, Fontella FU, Crema LM, Bonan CD, Dalmaz C, Barreto-Chaves ML, Sarkis JJ (2005) Hyperthyroidism changes nociceptive response and ecto-nucleotidase activities in synaptosomes from spinal cord of rats in different phases of development. Comp Biochem Physiol A Mol Integr Physiol 140:111\u2013116","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"9858_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neures.2005.01.009","volume":"52","author":"AN Bruno","year":"2005","unstructured":"Bruno AN, Diniz GP, Ricachenevsky FK, Pochmann D, Bonan CD, Barreto-Chaves ML, Sarkis JJ (2005) Hypo-and hyperthyroidism affect the ATP, ADP and AMP hydrolysis in rat hippocampal and cortical slices. Neurosci Res 52:61\u201368","journal-title":"Neurosci Res"},{"key":"9858_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbr.2005.09.017","volume":"167","author":"AN Bruno","year":"2006","unstructured":"Bruno AN, Fontella FU, Bonan CD, Barreto-Chaves ML, Dalmaz C, Sarkis JJ (2006) Activation of adenosine A(1) receptors alters behavioral and biochemical parameters in hyperthyroid rats. Behav Brain Res 167:287\u2013294","journal-title":"Behav Brain Res"},{"key":"9858_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/0953710042000260164","volume":"16","author":"AN Bruno","year":"2005","unstructured":"Bruno AN, Pochmann D, Ricachenevsky FK, Bonan CD, Barreto-Chaves ML, Freitas SJ (2005) 5\u2019-nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats. Platelets 16:25\u201330","journal-title":"Platelets"},{"key":"9858_CR65","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1002\/jcb.26856","volume":"119","author":"J Baldissarelli","year":"2018","unstructured":"Baldissarelli J, Santi A, Schmatz R, Martins CC, Zanini D, Reichert KP, Thom\u00e9 GR, Palma TV, Da CP, Morsch VM, Schetinger M (2018) Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets. J Cell Biochem 119:6249\u20136257","journal-title":"J Cell Biochem"},{"key":"9858_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/A:1014412814735","volume":"231","author":"N Balas","year":"2002","unstructured":"Balas N, Arad M, Rabinowitz B, Shainberg A (2002) Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate. Mol Cell Biochem 231:107\u2013116","journal-title":"Mol Cell Biochem"},{"key":"9858_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cardiores.2006.03.006","volume":"71","author":"L Willems","year":"2006","unstructured":"Willems L, Reichelt ME, Molina JG, Sun CX, Chunn JL, Ashton KJ, Schnermann J, Blackburn MR, Headrick JP (2006) Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res 71:79\u201387","journal-title":"Cardiovasc Res"},{"key":"9858_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mce.2006.02.010","volume":"251","author":"ML Barreto-Chaves","year":"2006","unstructured":"Barreto-Chaves ML, Carneiro-Ramos MS, Cotomacci G, J\u00fanior MB, Sarkis JJ (2006) E-NTPDase 3 (ATP diphosphohydrolase) from cardiomyocytes, activity and expression are modulated by thyroid hormone. Mol Cell Endocrinol 251:49\u201355","journal-title":"Mol Cell Endocrinol"},{"key":"9858_CR69","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.phrs.2007.04.017","volume":"56","author":"A Kemeny-Beke","year":"2007","unstructured":"Kemeny-Beke A, Jakab A, Zsuga J, Vecsernyes M, Karsai D, Pasztor F, Grenczer M, Szentmiklosi AJ, Berta A, Gesztelyi R (2007) Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium. Pharmacol Res 56:124\u2013131","journal-title":"Pharmacol Res"},{"key":"9858_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1385\/CBB:47:1:45","volume":"47","author":"D Karsai","year":"2007","unstructured":"Karsai D, Gesztelyi R, Zsuga J, Jakab A, Szendrei L, Juhasz B, Bak I, Szabo G, Lekli I, Vecsernyes M, Varga E, Szentmiklosi AJ, Tosaki A (2007) Influence of hyperthyroidism on the effect of adenosine transport blockade assessed by a novel method in guinea pig atria. Cell Biochem Biophys 47:45\u201352","journal-title":"Cell Biochem Biophys"},{"key":"9858_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.lfs.2012.06.023","volume":"91","author":"G Cotomacci","year":"2012","unstructured":"Cotomacci G, Sarkis JJ, F\u00fcrstenau CR, Barreto-Chaves ML (2012) Thyroid hormones are involved in 5\u2019-nucleotidase modulation in soluble fraction of cardiac tissue. Life Sci 91:137\u2013142","journal-title":"Life Sci"},{"key":"9858_CR72","doi-asserted-by":"publisher","first-page":"110594","DOI":"10.1016\/j.mce.2019.110594","volume":"499","author":"J Baldissarelli","year":"2020","unstructured":"Baldissarelli J, M\u00e2nica A, Pillat MM, Bagatini MD, Leal D, Abdalla FH, Morsch VM, Ulrich H, Bornemann CP, Chitolina SM (2020) Increased cytokines production and oxidative stress are related with purinergic signaling and cell survival in post-thyroidectomy hypothyroidism. Mol Cell Endocrinol 499:110594","journal-title":"Mol Cell Endocrinol"},{"key":"9858_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijdevneu.2004.09.003","volume":"23","author":"AN Bruno","year":"2005","unstructured":"Bruno AN, Ricachenevsky FK, Pochmann D, Bonan CD, Battastini AM, Barreto-Chaves ML, Sarkis JJ (2005) Hypothyroidism changes adenine nucleotide hydrolysis in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int J Dev Neurosci 23:37\u201344","journal-title":"Int J Dev Neurosci"},{"key":"9858_CR74","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s11064-005-7867-3","volume":"30","author":"AN Bruno","year":"2005","unstructured":"Bruno AN, Pochmann D, Ricachenevsky FK, Fontella FU, Bonan CD, Dalmaz C, Barreto-Chaves ML, Sarkis JJ (2005) Nociceptive response and adenine nucleotide hydrolysis in synaptosomes isolated from spinal cord of hypothyroid rats. Neurochem Res 30:1155\u20131161","journal-title":"Neurochem Res"},{"key":"9858_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11064-006-9041-y","volume":"31","author":"E Braganhol","year":"2006","unstructured":"Braganhol E, Bruno AN, Bavaresco L, Barreto-Chaves ML, Sarkis JJ, Battastini AM (2006) Neonatal hypothyroidism affects the adenine nucleotides metabolism in astrocyte cultures from rat brain. Neurochem Res 31:449\u2013454","journal-title":"Neurochem Res"},{"key":"9858_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10571-016-0342-7","volume":"37","author":"J Baldissarelli","year":"2017","unstructured":"Baldissarelli J, Santi A, Schmatz R, Abdalla FH, Cardoso AM, Martins CC, Dias GR, Calgaroto NS, Pelinson LP, Reichert KP, Loro VL, Morsch VM, Schetinger MR (2017) Hypothyroidism enhanced ectonucleotidases and acetylcholinesterase activities in rat synaptosomes can be prevented by the naturally occurring polyphenol quercetin. Cell Mol Neurobiol 37:53\u201363","journal-title":"Cell Mol Neurobiol"},{"key":"9858_CR77","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.biopha.2016.10.109","volume":"84","author":"J Baldissarelli","year":"2016","unstructured":"Baldissarelli J, Santi A, Schmatz R, Zanini D, Cardoso AM, Abadalla FH, Thom\u00e9 GR, Murussi C, Polachini C, Delenogare DP, Loro VL, Morsch VM, Schetinger M (2016) Quercetin changes purinergic enzyme activities and oxidative profile in platelets of rats with hypothyroidism. Biomed Pharmacother 84:1849\u20131857","journal-title":"Biomed Pharmacother"},{"key":"9858_CR78","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1210\/jc.2015-1726","volume":"100","author":"R Lupoli","year":"2015","unstructured":"Lupoli R, Di Minno MN, Tortora A, Scaravilli A, Cacciapuoti M, Barba L, Di Minno A, Ambrosino P, Lupoli GA, Lupoli G (2015) Primary and secondary hemostasis in patients with subclinical hypothyroidism: effect of levothyroxine treatment. J Clin Endocrinol Metab 100:2659\u20132665","journal-title":"J Clin Endocrinol Metab"},{"key":"9858_CR79","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/09537104.2017.1361017","volume":"29","author":"J Baldissarelli","year":"2018","unstructured":"Baldissarelli J, Pillat MM, Schmatz R, Cardoso AM, Abdalla FH, de Oliveira JS, Polachini C, Casali E, Bornemann CP, Ulrich H, Morsch VM, Schetinger M (2018) Post-thyroidectomy hypothyroidism increases the expression and activity of ectonucleotidases in platelets: possible involvement of reactive oxygen species. Platelets 29:801\u2013810","journal-title":"Platelets"},{"key":"9858_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lfs.2006.08.020","volume":"80","author":"A Zamoner","year":"2006","unstructured":"Zamoner A, Bruno AN, Casali EA, Corbelini PF, Diniz GP, Barreto-Chaves ML, Silva FR, Sarkis JJ, Pessoa-Pureur R (2006) Genomic-independent action of thyroid hormones on NTPDase activities in Sertoli cell cultures from congenital hypothyroid rats. Life Sci 80:51\u201358","journal-title":"Life Sci"},{"key":"9858_CR81","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11255-008-9332-0","volume":"40","author":"MK Yildirim","year":"2008","unstructured":"Yildirim MK, Bagcivan I, Sarac B, Kilicarslan H, Yildirim S, Kaya T (2008) Effect of hypothyroidism on the purinergic responses of corpus cavernosal smooth muscle in rabbits. Int Urol Nephrol 40:691\u2013699","journal-title":"Int Urol Nephrol"},{"key":"9858_CR82","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1210\/en.2007-1223","volume":"149","author":"A Solini","year":"2008","unstructured":"Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di Virgilio F, Monzani F (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 149:389\u2013396","journal-title":"Endocrinology"},{"key":"9858_CR83","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1210\/jc.2008-1322","volume":"94","author":"A Dardano","year":"2009","unstructured":"Dardano A, Falzoni S, Caraccio N, Polini A, Tognini S, Solini A, Berti P, Di Virgilio F, Monzani F (2009) 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. J Clin Endocrinol Metab 94:695\u2013698","journal-title":"J Clin Endocrinol Metab"},{"key":"9858_CR84","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12020-010-9384-7","volume":"38","author":"LQ Gu","year":"2010","unstructured":"Gu LQ, Li FY, Zhao L, Liu Y, Chu Q, Zang XX, Liu JM, Ning G, Zhao YJ (2010) Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma. Endocrine 38:276\u2013282","journal-title":"Endocrine"},{"key":"9858_CR85","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1124\/jpet.109.152447","volume":"330","author":"DM Yang","year":"2009","unstructured":"Yang DM, Teng HC, Chen KH, Tsai ML, Lee TK, Chou YC, Chi CW, Chiou SH, Lee CH (2009) Clodronate-induced cell apoptosis in human thyroid carcinoma is mediated via the P2 receptor signaling pathway. J Pharmacol Exp Ther 330:613\u2013623","journal-title":"J Pharmacol Exp Ther"},{"key":"9858_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.20704","volume":"209","author":"A Pines","year":"2006","unstructured":"Pines A, Bivi N, Vascotto C, Romanello M, D\u2019Ambrosio C, Scaloni A, Damante G, Morisi R, Filetti S, Ferretti E, Quadrifoglio F, Tell G (2006) Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1\/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway. J Cell Physiol 209:44\u201355","journal-title":"J Cell Physiol"},{"key":"9858_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12307-018-0206-4","volume":"11","author":"A Bertoni","year":"2018","unstructured":"Bertoni A, de Campos RP, Tsao M, Braganhol E, Furlanetto TW, Wink MR (2018) Extracellular ATP is differentially metabolized on papillary thyroid carcinoma cells surface in comparison to normal cells. Cancer Microenviron 11:61\u201370","journal-title":"Cancer Microenviron"},{"key":"9858_CR88","doi-asserted-by":"crossref","unstructured":"Jeong YM, Cho H, Kim TM, Kim Y, Jeon S, Bychkov A, Jung CK (2020) CD73 Overexpression promotes progression and recurrence of papillary thyroid carcinoma. Cancers (Basel) 12:3042","DOI":"10.3390\/cancers12103042"},{"key":"9858_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00428-021-03100-x","volume":"479","author":"I Monteiro","year":"2021","unstructured":"Monteiro I, Missiaglia E, Sciarra A, Santos JV, Bouilly J, Romero P, Sempoux C, de Leval L (2021) CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas. Virchows Arch 479:209\u2013214","journal-title":"Virchows Arch"},{"key":"9858_CR90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mce.2018.08.013","volume":"479","author":"A Bertoni","year":"2019","unstructured":"Bertoni A, Bracco PA, de Campos RP, Lutz BS, Assis-Brasil BM, Meyer E, Saffi J, Braganhol E, Furlanetto TW, Wink MR (2019) Activity of ecto-5\u2019-nucleotidase (NT5E\/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes. Mol Cell Endocrinol 479:54\u201360","journal-title":"Mol Cell Endocrinol"},{"key":"9858_CR91","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1210\/en.2019-00241","volume":"160","author":"E Abbasifarid","year":"2019","unstructured":"Abbasifarid E, Sajjadi-Jazi SM, Beheshtian M, Samimi H, Larijani B, Haghpanah V (2019) The role of ATP-binding cassette transporters in the chemoresistance of anaplastic thyroid cancer: a systematic review. Endocrinology 160:2015\u20132023","journal-title":"Endocrinology"},{"key":"9858_CR92","doi-asserted-by":"publisher","first-page":"664","DOI":"10.21037\/atm-21-505","volume":"9","author":"Y Guan","year":"2021","unstructured":"Guan Y, Li Y, Yang QB, Yu J, Qiao H (2021) LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt\/\u03b2-catenin signaling pathway. Ann Transl Med 9:664","journal-title":"Ann Transl Med"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-022-09858-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T18:08:55Z","timestamp":1677866935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-022-09858-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["9858"],"URL":"https:\/\/doi.org\/10.1007\/s11302-022-09858-2","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Ying Le declares that he\/she has no conflict of interest.Donghui Lu declares that he\/she has no conflict of interest.Meng Xue declares that he\/she has no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}